Tag Archives: NVCR

NovoCure Limited (NVCR)

NovoCure Limited is a commercial-stage oncology company. The Company is engaged in developing a therapy called TTFields for the treatment of solid tumor cancers. TTFields is a low-toxicity anti-mitotic treatment that uses low-intensity, intermediate frequency, alternating electric fields to exert physical forces on molecules inside cancer cells, disrupting the basic machinery for normal cell division,....More>>>

News about NVCR

Benzinga's Option Alert Recap From September 18
From:www.benzinga.com
Related AXON Oppenheimer Presents New Menu Of Top Picks Arena Upgraded, Analyst Sees 44% Upside Related LEN 25 Stocks Moving In Tuesday's Pre-Market Session Homebuilders U...Read More>>>

3 Things In Biotech You Should Learn Today: April 21, 2017
From:seekingalpha.com
Welcome to another edition of "3 Things in Biotech You Should Learn Today," a series covering actionable updates in the biotech community. Here, you might learn some new information about companies you know about as well as news for companies that ma...Read More>>>

3 Things In Biotech You Should Learn Today: April 20, 2017
From:seekingalpha.com
Welcome to another installment of "3 Things in Biotech You Should Learn Today." In this episode, we're going to consider the news of a few "out there" technologies, namely CRISPR gene editing and tumor-treating fields. Then, we'll come back to someth...Read More>>>

NovoCure's Story Keeps Getting Better
From:seekingalpha.com
Shares of NovoCure (NASDAQ:NVCR) have risen roughly 25% since I called them a "buying opportunity", speculating that mature pivotal data and accelerated adoption of Optune were potential catalysts for a turnaround in the company's fortunes. NVCR d...Read More>>>

Ceviche Fund Updates: Numbers And New Trades
From:seekingalpha.com
In a short period of time readers and I have been pleasantly surprised by the outperformance of this model portfolio. Click to enlarge Figure 1: Ceviche Fund Snapshot November 19th While the fund takes a "go anywhere" approach, lately the opportuni...Read More>>>